Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis

Contact Dermatitis
Sibylle SchliemannPeter Elsner

Abstract

Occupational hand dermatitis (OHD) is a common and often chronic condition. Usage of topical corticosteroids is limited in long-term therapy because of potential side-effects. New treatment options are highly appreciated. To study efficacy and safety of tacrolimus in patients suffering from OHD. In a prospective, open, multicentre study, 29 patients with OHD of predominantly mild-to-moderate severity were treated with tacrolimus ointment (Protopic 0.1%) during a 4-week active treatment period with twice daily application followed by a 2-month optional treatment period. Efficacy was evaluated by the use of a standardized hand eczema score and by clinical severity rating, conducted on all study visits (screening, baseline and weeks 2, 4, 6, and 12). Adverse events were recorded for safety evaluation. The hand eczema score declined significantly after 2 weeks of treatment compared with baseline and further declined until the end of the study. Finally, 12 (44%) patients were clear of hand eczema. Worsening of the dermatitis occurred in 2 patients (7%). Clinical grading indicated improvement too. Overall tolerability was good. Topical tacrolimus might be an efficacious treatment option for chronic OHD. Blinded and randomized control...Continue Reading

References

Jan 5, 2001·Contact Dermatitis·U BerndtP Elsner
Mar 22, 2001·Contact Dermatitis·E HeldT Agner
Sep 5, 2001·The British Journal of Dermatology·H DickelT L Diepgen
Oct 5, 2001·Expert Opinion on Pharmacotherapy·T AssmannT Ruzicka
Jan 5, 2002·Journal of the American Academy of Dermatology·Christina SchnoppDietrich Abeck
May 16, 2002·American Journal of Clinical Dermatology·Heinrich DickelThomas L Diepgen
Aug 13, 2002·International Archives of Occupational and Environmental Health·Andrea BauerHywel Williams
Apr 30, 2003·International Archives of Occupational and Environmental Health·Hans Joachim SchwanitzBritta Wulfhorst
May 28, 2003·International Archives of Occupational and Environmental Health·Peter-Jan Coenraads, Thomas L Diepgen
Jun 13, 2003·International Archives of Occupational and Environmental Health·P Elsner, W Wigger-Alberti
Jun 27, 2003·International Archives of Occupational and Environmental Health·Ai-Lean Chew, Howard I Maibach
Jul 4, 2003·The Journal of Investigative Dermatology·Heinrich DickelThomas L Diepgen
Aug 2, 2003·Journal of the American Academy of Dermatology·Heinrich Dickel, Swen Malte John
Nov 26, 2003·Journal of the American Academy of Dermatology·Deana L KadykDonald V Belsito
Dec 24, 2004·The New England Journal of Medicine·Jann Lübbe, Maria Milingou
Feb 24, 2005·Dermatitis : Contact, Atopic, Occupational, Drug·Bryan E AndersonDavid T Mauger
Feb 26, 2005·International Archives of Occupational and Environmental Health·Nanna Y SchürerHans J Schwanitz
Apr 29, 2005·Journal of the European Academy of Dermatology and Venereology : JEADV·U DarsowUNKNOWN European Task Force on Atopic Dermatitis
Jul 16, 2005·Journal of the American Academy of Dermatology·Jon M HanifinUNKNOWN US Tacrolimus Ointment Study Group
Nov 12, 2005·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Christoph Skudlik, Hans Joachim Schwanitz
Nov 12, 2005·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas LugerThomas Schwarz
Dec 21, 2005·Contact Dermatitis·B MedingB Bengtsson
Feb 21, 2006·Contact Dermatitis·Rikke Skoet CvetkovskiTove Agner
Mar 22, 2006·Archives of Dermatology·Rikke Skoet CvetkovskiTove Agner
May 13, 2006·Contact Dermatitis·Elke WeisshaarThomas L Diepgen
Apr 27, 2007·Dermatology : International Journal for Clinical and Investigative Dermatology·David J MargolisWarren Bilker
May 12, 2007·American Journal of Clinical Dermatology·Uwe Wollina

❮ Previous
Next ❯

Citations

Aug 16, 2008·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·U RaapT Werfel
Aug 1, 2009·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S Soost, M Worm
Mar 24, 2010·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·H SchwantesP Elsner
Oct 24, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C SkudlikS M John
Nov 19, 2009·Drug Design, Development and Therapy·Bibi Petersen, Gregor B E Jemec
Sep 18, 2014·Current Allergy and Asthma Reports·Lindsey WoldHeather P Lampel
Apr 27, 2010·Annales de dermatologie et de vénéréologie·P Berbis
Apr 27, 2010·Annales de dermatologie et de vénéréologie·B HaliouaUNKNOWN Groupe d'experts sur l'eczéma chronique des mains
Oct 7, 2010·Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·A ClemmensenK E Andersen
May 26, 2015·Actas dermo-sifiliográficas·F J de LeónJ F Silvestre
Apr 30, 2015·American Journal of Clinical Dermatology·Dimitar AntonovPeter Elsner
Jun 24, 2014·Annales de dermatologie et de vénéréologie·M Lahfa
Jan 30, 2019·Dermatologic Therapy·Griffin R LeeVivian Y Shi
Jul 16, 2010·The Journal of Dermatology·Virendra N SehgalAlpna D Sharma
Sep 25, 2009·The Journal of Laryngology and Otology·J-P VercruysseE Offeciers
Sep 14, 2019·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·E Berthold, E Weisshaar
Dec 21, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·P Elsner, T Agner
Aug 11, 2020·The Australasian Journal of Dermatology·Marius RademakerLi-Chuen Wong
May 10, 2019·Dermatologic Therapy·Premjit Juntongjin, Ratchasin Pongprasert
Jan 8, 2021·Therapeutics and Clinical Risk Management·Celina DubinEmma Guttman-Yassky
Jul 16, 2021·Clinical Reviews in Allergy & Immunology·Yan Li, Linfeng Li
Mar 25, 2009·Current Opinion in Allergy and Clinical Immunology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.